Maxacalcitol/betamethasone butyrate propionate regulatory update

Chugai submitted an NDA in Japan for M8010 to treat psoriasis vulgaris. M8010 is a topical combination of Oxarol maxacalcitol, an active vitamin D3 derivative from Chugai, and betamethasone butyrate p...